1. Ling, Han, Cao, Chen-Hui, Han, Kai, Xie, Dan, Wang, Feng-Wei. 2022. CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1. In Oncogene, 41, 4433-4445. doi:10.1038/s41388-022-02439-y. https://pubmed.ncbi.nlm.nih.gov/35989368/
2. Liu, Chenguang, Yu, Fangqin, Ma, Runsheng, Niu, Dongpeng, Yin, Detao. 2021. Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC‑1. In Oncology reports, 46, . doi:10.3892/or.2021.8150. https://pubmed.ncbi.nlm.nih.gov/34296302/
3. Zhao, Huijie, Zhu, Lei, Zhu, Yunlu, Yan, Xiumin, Zhu, Xueliang. 2013. The Cep63 paralogue Deup1 enables massive de novo centriole biogenesis for vertebrate multiciliogenesis. In Nature cell biology, 15, 1434-44. doi:10.1038/ncb2880. https://pubmed.ncbi.nlm.nih.gov/24240477/
4. Pekkola Pacheco, Nadja, Pettersson, Maria, Lindstrand, Anna, Grigelioniene, Giedre. 2023. Expanding the phenotype of Seckel syndrome associated with biallelic loss-of-function variants in CEP63. In American journal of medical genetics. Part A, 191, 1929-1934. doi:10.1002/ajmg.a.63200. https://pubmed.ncbi.nlm.nih.gov/37017437/
5. Sir, Joo-Hee, Barr, Alexis R, Nicholas, Adeline K, Woods, C Geoffrey, Gergely, Fanni. 2011. A primary microcephaly protein complex forms a ring around parental centrioles. In Nature genetics, 43, 1147-53. doi:10.1038/ng.971. https://pubmed.ncbi.nlm.nih.gov/21983783/
6. Cai, Zhao, Chen, Huang, Bai, Jingqiao, Shou, Jianzhong, Gao, Yanning. 2021. Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer. In Frontiers in oncology, 11, 674933. doi:10.3389/fonc.2021.674933. https://pubmed.ncbi.nlm.nih.gov/34041036/